TGF-β and cancer

被引:353
作者
Bierie, B
Moses, HL
机构
[1] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[3] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA
关键词
TGF-beta; Smad; cancer; stroma; epithelium; interactions; cross-talk;
D O I
10.1016/j.cytogfr.2005.09.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TGF-beta signaling regulates tumorigenesis and ill human cancer its signaling pathways are often modified during tumor progression. Prior to initiation and early during progression TGF-beta acts upon the epithelium as a tumor Suppressor, however at later stages it is often a tumor promoter. Over the years, many studies have focused on the epithelial cell autonomous role for TGF-beta, however, TGF-beta is not strictly limited to this compartment in vivo. Recent studies addressing TGF-beta mediated stromal-epithelial interactions have significantly improved our understanding related to the regulation of cancer. In addition, stromal fibroblast cell autonomous effects have been observed in response to TGF-beta stimulation. According to the current literature and experimental evidence, TGF-beta is a potent ligand that regulates carcinoma initiation, progression and metastasis through a broad and complex spectrum of interdependent interactions. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:29 / 40
页数:12
相关论文
共 116 条
  • [1] TGF-β signaling in cancer -: a double-edged sword
    Akhurst, RJ
    Derynck, R
    [J]. TRENDS IN CELL BIOLOGY, 2001, 11 (11) : S44 - S51
  • [2] Molecular characterization of the tumor microenvironment in breast cancer
    Allinen, M
    Beroukhim, R
    Cai, L
    Brennan, C
    Lahti-Domenici, J
    Huang, HY
    Porter, D
    Hu, M
    Chin, L
    Richardson, A
    Schnitt, S
    Sellers, WR
    Polyak, K
    [J]. CANCER CELL, 2004, 6 (01) : 17 - 32
  • [3] Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development
    Amendt, C
    Schirmacher, P
    Weber, H
    Blessing, M
    [J]. ONCOGENE, 1998, 17 (01) : 25 - 34
  • [4] Anbazhagan R, 1999, CANCER RES, V59, P3363
  • [5] Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration
    Bakin, AV
    Tomlinson, AK
    Bhowmick, NA
    Moses, HL
    Arteaga, CL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (47) : 36803 - 36810
  • [6] Bakin AV, 2002, J CELL SCI, V115, P3193
  • [7] Bandyopadhyay A, 1999, CANCER RES, V59, P5041
  • [8] Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254
  • [9] Higher stromal expression of transforming growth factor-beta type II receptors is associated with poorer prognosis breast tumors
    Barlow, J
    Yandell, D
    Weaver, D
    Casey, T
    Plaut, K
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 79 (02) : 149 - 159
  • [10] Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia
    Berger, AP
    Kofler, K
    Bektic, J
    Rogatsch, H
    Steiner, H
    Bartsch, G
    Klocker, H
    [J]. PROSTATE, 2003, 57 (01) : 57 - 65